Frontage Holdings Corporation (FGHQF)
OTCMKTS · Delayed Price · Currency is USD
0.1010
-0.0190 (-15.83%)
At close: Jun 21, 2024

Frontage Holdings Company Description

Frontage Holdings Corporation, a contract research organization, provides laboratory and related services to pharmaceutical, biotechnology, and agrochemical companies.

It offers drug discovery services comprising medicinal chemistry, pharmacology, and efficacy, as well as absorption, distribution, metabolism, and excretion (ADME) screening.

The company also provides drug metabolism and pharmacokinetics (DMPK); safety and toxicology; early phase clinical services; and bioequivalence and related services, such as pharmacology, medical writing, and regulatory support.

In addition, it offers pharmaceutical product development services, including intermediate and active pharmaceutical ingredient (API) synthesis, process and formulation development, and clinical trial material manufacturing.

Further, the company provides laboratory testing services, such as bioanalysis, biomarkers, genomics, CMC Analytical testing, and central laboratory services.

It operates in the United States, Canada, the People’s Republic of China, Europe, India, Japan, South Korea, and Australia.

The company was incorporated in 2018 and is headquartered in Exton, Pennsylvania. Frontage Holdings Corporation operates as a subsidiary of Hongkong Tigermed Co., Limited.

Frontage Holdings Corporation
Frontage Holdings logo
Country Cayman Islands
Founded 2018
Industry Biotechnology
Sector Healthcare
Employees 1,560
CEO Abdul Mutlib

Contact Details

Address:
700 Pennsylvania Drive
Exton, 19341
United States
Phone 610 232 0100
Website frontagelab.com

Stock Details

Ticker Symbol FGHQF
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
ISIN Number KYG3679P1019
SIC Code 8731

Key Executives

Name Position
Dr. Wentao Zhang Ph.D. Co-Chief Executive Officer
Dr. Zhongping Lin Ph.D. Co-Chief Executive Officer
Dr. Song Li Ph.D. Founder and Chairman
Dr. Abdul Ezaz Mutlib Ph.D. Chief Scientific and Strategy Officer
Jun Gao Chief Financial Officer and President of Asia Pacific
Richard Fischetti J.D. Vice President and General Counsel of Frontage Labs
Dr. Dongmei Wang Ph.D. Executive Vice President of Global Sales and Marketing and Project Management
Dr. Tianyi Zhang Senior Vice President of the Group and GM of Frontage Shanghai
Sudendra Rao Ph.D. Senior Vice President of Human Resources - North America
Dr. John Kapeghian Ph.D. Executive Vice President of Global Safety and Toxicology